Cardiac marker analyzer, also known as cardiac reader system, is an important tool to prevent misdiagnoses of cardiac conditions such as myocardial infarction. These analyzers measure the level of cardiac troponin, creatine kinase-muscle/brain (CK-MB), myoglobin, and/or D-dimer through immunochromatographic assays within 15 minutes.

Increase in focus on preventing misdiagnoses of cardiac conditions, rise in prevalence of cardiac diseases such as acute coronary syndrome (ACS), myocardial infarction, cardiac heart failure, and others are anticipated to drive the growth of the cardiac marker analyzers market during the forecast period. Moreover, increase in the number of patients underdoing cardiac surgeries in hospitals & ambulatory care centers and rise in awareness about the availability of new products for the diagnosis of cardiovascular diseases are other factor that contribute to the growth of the cardiac marker analyzers market. According to the American Heart Association, cardiovascular disease is one of the most common causes of mortality, accounting for nearly 17 million deaths (30% of total deaths) globally each year. The number is expected to increase to over 23.6 million by 2030.

Rise in the number of cardiac procedures such as coronary bypass surgeries and increase in the geriatric population are anticipated to drive the global cardiac marker analyzers market. According to the American Heart Association, over 5 million people in the U.S. are diagnosed with heart valve disease each year, many of them not showing any symptoms. According to the Texas Heart Institute, 500,000 coronary bypass procedures are performed in the U.S. each year. According to the European Union, 55,000 coronary bypass procedures are performed in Germany each year. According to the U.S. Census Board, people older than 65 years represented around 13% of the total population of the U.S., and the percentage is expected to reach 20% by 2030. According to the WHO, the global geriatric population is likely to reach 1.5 billion by 2050. Other countries aging at a rapid pace are the U.S., Japan, and Germany.

The global cardiac marker analyzers market can be segmented based on product, end-user, and region. In terms of product, the cardiac marker analyzers market can be divided into immunofluorescence analyzers (IFA), magnetic immunochromatographic assay (MICA) analyzers, chemiluminiscenece immunoassay (CLIA) analyzers, radioimmunoassay (RIA) analyzers, and enzyme immunoassay (EIA) analyzers. The immunofluorescence analyzers (IFA) segment is projected to expand at the fastest CAGR during the forecast period due to increase in demand for these analyzers for early diagnosis of cardiac diseases and large number of manufacturers of immunofluorescence analyzers. Based on end-user, the global cardiac marker analyzers market can be categorized into hospitals, ambulatory care centers, diagnostics centers, and academic & research institutes. The hospitals segment is anticipated to account for the largest market share owing to increase in the number of cardiac surgeries in hospitals and availability of technologically advanced diagnostic tools for rapid analysis.

The global cardiac marker analyzers market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for the largest cardiac marker analyzers market share due to increase in demand for point-of-care testing devices, rise in focus on providing immediate diagnostic and treatment services to cardiac patients, and new products launched by the major players. Moreover, prevalence of heart diseases is increasing in the region. According to American Heart Association, more than 5 million people in the U.S. are diagnosed with heart valve disease each year, many of them not showing any symptoms.

Key players operating in the global cardiac marker analyzers market are Abbott Laboratories, Beckman Coulter, Inc., LSI Medience Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Radiometer Medical Aps, Mitsubishi Chemical Europe GmbH, LifeSign LLC., CardioGenics, Inc., and Boditech Med, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Cardiac Marker Analyzers Market

Pre Book